Summit Therapeutics SMMT United Kingdom — Long-Lived Assets
Discontinued — last reported Q3 '24
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NoncurrentAssets.
The official record: Summit Therapeutics’s 10-Q, filed October 30, 2024, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's united kingdom — long-lived assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's united kingdom — long-lived assets?
- Summit Therapeutics (SMMT) reported united kingdom — long-lived assets of $660K in Q3 2024.
- How has Summit Therapeutics's united kingdom — long-lived assets changed year-over-year?
- Summit Therapeutics's united kingdom — long-lived assets decreased by 20.7% year-over-year, from $832K to $660K.
- What does united kingdom — long-lived assets mean?
- The total value of long-term assets, such as property and equipment, located in the United Kingdom.
- How do you interpret united kingdom — long-lived assets?
- An increase suggests capital expansion or investment in regional infrastructure, while a decrease may indicate asset depreciation, divestiture, or a strategic shift in geographic focus.
- How does united kingdom — long-lived assets compare across companies?
- Comparable to geographic property, plant, and equipment (PP&E) disclosures found in the segment reporting notes of other multinational biopharmaceutical firms.